Background/Objectives: The accurate categorization of brain MRI images into tumor and non-tumor categories is essential for a prompt and effective diagnosis. This paper presents a novel methodology utilizing advanced Convolutional Neural Network (CNN) designs to tackle the complexity and unpredictability present in brain MRI data. Methods: The methodology commences with an extensive preparation phase that includes image resizing, grayscale conversion, Gaussian blurring, and the delineation of the brain region for preparing the MRI images for analysis. The Multi-verse Optimizer (MVO) is utilized to optimize data augmentation parameters and refine the configuration of trainable layers in VGG16 and ResNet50. The model’s generalization capabilities are significantly improved by the MVO’s ability to effectively balance computational cost and performance. Results: The amalgamation of VGG16 and ResNet50, further refined by the MVO, exhibits substantial enhancements in classification metrics. The MVO-optimized hybrid model demonstrates enhanced performance, exhibiting a well-calibrated balance between precision and recall, rendering it exceptionally trustworthy for medical diagnostic applications. Conclusions: The results highlight the effectiveness of MVO-optimized CNN models for classifying brain tumors in MRI data. Future investigations may examine the model’s applicability to multiclass issues and its validation in practical clinical environments.
This research presents a novel methodology for classifying MRI images into two categories: tumor and non-tumor. The study utilizes a combination of two advanced Convolutional Neural Network (CNN) architectures, VGG16 and ResNet50, to address the challenges in analyzing the complexity and variability of brain MRI scans. The approach begins with a comprehensive preprocessing phase, where the MRI images are enhanced through techniques such as resizing, grayscale conversion, Gaussian blurring, and brain area isolation. Central to the approach is the application of the Multi-verse Optimizer (MVO), a metaheuristic algorithm inspired by theories of the multi-verse in physics. The MVO is utilized to optimize the parameters for data augmentation and to fine-tune the combination of trainable layers within the VGG16 and ResNet50 models. The results of this study indicate a high level of effectiveness of the combined CNN models, significantly enhanced by the MVO, in classifying MRI images. These models show marked improvements in accuracy, precision, and recall, underscoring their potential utility in enhancing brain tumor diagnosis. The paper concludes with an analysis of these findings, emphasizing the importance of this approach in medical imaging and suggesting potential avenues for future research in the area of automated MRI classification.
Background/Objectives: Brain tumor segmentation is critical for accurate identification and treatment planning. However, delineating intricate tumor areas like Edema, Tumor Core, and Enhancing Tumor remains challenging owing to diversity in dimensions, morphology, and delineation. Methods: This introduces an innovative a novel deep learning model integrating a Pretrained Vision Transformer (ViT) for global context representation, Atrous Spatial Pyramid Pooling (ASPP) in both encoder and merging stages, and ReLU6. Additionally, attention mechanisms and Conditional Random Fields (CRF) were incorporated for refining feature emphasis and segmentation boundaries. Results: The model was trained and tested on the BraTS 2020 dataset and compared with state-of-the-art methods. The suggested model obtained the highest Dice coefficients across all tumor regions, with improvements of up to 4% for Enhancing Tumor and Edema. Grad-CAM heatmaps illustrated the model's proficiency in precisely identifying tumor areas, hence enhancing the interpretability of predictions. Conclusions: The incorporation of multi-scale feature extraction, attention mechanism, and global context representation markedly improved segmentation accuracy and interpretability. The findings underscore the proposed model's capacity to enhance clinical processes and establish a standard for brain tumor segmentation tasks. Future endeavors involve testing on varied datasets and investigating lightweight structures for real-time applications.